Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Anesthetic Recalled
01/26/2023
Jolynn Tumolo
A Class II recall has been issued for more than 100,000 vials of an anesthetic due to subpotency.
A Class II recall has been issued for more than 100,000 vials of an anesthetic due to subpotency.
A Class II recall has been...
01/26/2023
Pharmacy Learning Network
News
Blood Pressure Drug Recalled
01/26/2023
Jolynn Tumolo
A prescription medication used to treat hypertension and edema has been recalled for failing to meet impurity and degradation specifications.
A prescription medication used to treat hypertension and edema has been recalled for failing to meet impurity and degradation specifications.
A prescription medication used...
01/26/2023
Pharmacy Learning Network

Advertisement

News
Akorn Recalls Dozens of Ophthalmic Medications
01/26/2023
Jolynn Tumolo
Included in the recall are antibiotics, beta blockers, antihistamines, and several other classes of medications intended for patient and clinician use.
Included in the recall are antibiotics, beta blockers, antihistamines, and several other classes of medications intended for patient and clinician use.
Included in the recall are...
01/26/2023
Pharmacy Learning Network
News
Latino Teens Deputized as Health Educators to Discuss COVID-19 With Unvaccinated Individuals
01/24/2023

Heidi de Marco, Kaiser Health News

Heidi de Marco, Kaiser Health News ...
To increase vaccination rates, community health groups in California and other states are training high school students to disseminate COVID-19 information and resources to their communities.
To increase vaccination rates, community health groups in California and other states are training high school students to disseminate COVID-19 information and resources to their communities.
To increase vaccination rates,...
01/24/2023
Pharmacy Learning Network
News
What Older Americans Need to Know About Taking Nirmatrelvir/Ritonavir for COVID-19
01/19/2023

Judith Graham, Kaiser Health News

Judith Graham, Kaiser Health News ...
Infectious disease experts and geriatricians weigh in on the use of nirmatrelvir/ritonavir, commonly known as Paxlovid, in older adults with COVID-19.
Infectious disease experts and geriatricians weigh in on the use of nirmatrelvir/ritonavir, commonly known as Paxlovid, in older adults with COVID-19.
Infectious disease experts and...
01/19/2023
Pharmacy Learning Network

Advertisement

News
Sterility Concerns Prompt Muscle Relaxant Recall
01/19/2023
Jolynn Tumolo
Nephron Sterile Compounding Center is recalling several thousand syringes of a prescription drug used as an adjunct to general anesthesia.
Nephron Sterile Compounding Center is recalling several thousand syringes of a prescription drug used as an adjunct to general anesthesia.
Nephron Sterile Compounding...
01/19/2023
Pharmacy Learning Network
News
Antibiotic Recalled
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
Eye Injection Recalled
01/13/2023
Jolynn Tumolo
An intraocular injection solution is being recalled due to discolored raw material.
An intraocular injection solution is being recalled due to discolored raw material.
An intraocular injection...
01/13/2023
Pharmacy Learning Network

Advertisement

News
FDA Grants Accelerated Approval for New Alzheimer Disease Drug
01/06/2023
Maria Asimopoulos
Lecanemab is the second drug targeting the underlying pathophysiology of Alzheimer disease to receive approval.
Lecanemab is the second drug targeting the underlying pathophysiology of Alzheimer disease to receive approval.
Lecanemab is the second drug...
01/06/2023
First Report Managed Care
News
Glaucoma Medication Recalled
01/05/2023
Jolynn Tumolo
A recall has been issued for a prescription beta-blocker that failed to meet stability specifications.
A recall has been issued for a prescription beta-blocker that failed to meet stability specifications.
A recall has been issued for a...
01/05/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use